ERM transactivation is up-regulated by the repression of DNA binding after the PKA phosphorylation of a consensus site at the edge of the ETS domain

The final step of the transduction pathway is the activation of gene transcription, which is driven by kinase cascades leading to changes in the activity of many transcription factors. Among these latter, PEA3/E1AF, ER81/ETV1, and ERM, members of the well conserved PEA3 group from the Ets family are involved in these processes. We show here that protein kinase A (PKA) increases the transcriptional activity of human ERM and human ETV1, through a Ser residue situated at the edge of the ETS DNA-binding domain. PKA phosphorylation does not directly affect the ERM transactivation domains but does affect DNA binding activity. Unphosphorylated wild-type ERM bound DNA avidly, whereas after PKA phosphorylation it did so very weakly. Interestingly, S367A mutation significantly reduced the ERM-mediated transcription in the presence of the kinase, and the DNA binding of this mutant, although similar to that of unphosphorylated wild-type protein, was insensitive to PKA treatment. Mutations, which may mimic a phosphorylated serine, converted ERM from an efficient DNA-binding protein to a poor DNA binding one, with inefficiency of PKA phosphorylation. The present data clearly demonstrate a close correlation between the capacity of PKA to increase the transactivation of ERM and the drastic down-regulation of the binding of the ETS domain to the targeted DNA. What we thus demonstrate here is a relatively rare transcription activation mechanism through a decrease in DNA binding, probably by the shift of a non-active form of an Ets protein to a PKA-phosphorylated active one, which should be in a conformation permitting a transactivation domain to be active.

Antibody deficiency due to a missense mutation in CD19 demonstrates the importance of the conserved tryptophan 41 in immunoglobulin superfamily domain formation.

Immunoglobulin superfamily (IgSF) domains are conserved structures present in many proteins in eukaryotes and prokaryotes. These domains are well-capable of facilitating sequence variation, which is most clearly illustrated by the variable regions in immunoglobulins (Igs) and T cell receptors (TRs). We studied an antibody-deficient patient suffering from recurrent respiratory infections and with impaired antibody responses to vaccinations. Patient's B cells showed impaired Ca(2+) influx upon stimulation with anti-IgM and lacked detectable CD19 membrane expression. CD19 sequence analysis revealed a homozygous missense mutation resulting in a tryptophan to cystein (W52C) amino acid change. The affected tryptophan is CONSERVED-TRP 41 located on the C-strand of the first extracellular IgSF domain of CD19 and was found to be highly conserved, not only in mammalian CD19 proteins, but in nearly all characterized IgSF domains. Furthermore, the tryptophan is present in all variable domains in Ig and TR and was not mutated in 117 Ig class-switched transcripts of B cells from controls, despite an overall 10% amino acid change frequency. In vitro complementation studies and CD19 western blotting of patient's B cells demonstrated that the mutated protein remained immaturely glycosylated. This first missense mutation resulting in a CD19 deficiency demonstrates the crucial role of a highly conserved tryptophan in proper folding or stability of IgSF domains.

Stratégies reproductives et sex-ratio chez le termite Cavitermes tuberosus (Emerson, 1925) -- Biologie des Organismes et Ecologie

Recently shown in some termites, Asexual Queen Succession (AQS) is a reproductive strategy in which the primary queen is replaced by numerous parthenogenetically-produced neotenic queens that mate with the primary king. In contrast, the workforce and alate dispersers are produced sexually. If the primary king is replaced by a sexually-produced neotenic son, the matings between neotenic male and females beget asymmetries in the reproductive value of alates, promoting a female-biased alate sex-ratio. Cavitermes tuberosus (Termitidae: Termitinae) is a soil-feeding tropical species, which shows parthenogenetically-produced neotenics and an AQS syndrome. Our work aims to characterize the reproductive strategies in this species by determining (i) the developmental scheme, (ii) the genetic origin of sexuals, (iii) the level of genetic structure (analysis of 65 nests distributed in 14 sites) and (iv) the alate sex-ratio.Our results show that (i) neotenic females develop from the third or fourth nymphal instar; (ii) the majority of neotenic females (82%) are parthenogenetically-produced while only 2% of female alates are so; (iii) nests are differentiated within sites, indicating that the foundation of new nests mainly occurs by nuptial flights; (iv) numerical sex-ratio of alate-destined sexuals is balanced (SRN=0.509, IC95%=0.497-0.522) while investment sex-ratio is slightly female-biased (SRE=0.529, IC95%=0.517-0.542). Altogether, our results demonstrate AQS and its implications in C. tuberosus, and reveal particularities compared to other species in which AQS has been demonstrated: neotenic-headed nests are less frequent than primary-headed ones and neotenic females never become physogastric. AQS is found in various ecological contexts and seems phylogenetically more widespread than previously thought. This strategy shows some evolutionary advantages but these seem to differ depending on species.

Rett syndrome

Rett syndrome is one of the most common causes of complex disability in girls. It is characterized by early neurological regression that severely affects motor, cognitive and communication skills, by autonomic dysfunction and often a seizure disorder. It is a monogenic X-linked dominant neurodevelopmental disorder related to mutation in MECP2, which encodes the methyl-CpG-binding protein MeCP2. There are several mouse models either based on conditional knocking out of the Mecp2 gene or on a truncating mutation. We discuss the clinical aspects with special emphasis on the behavioral phenotype and we review current perspectives in clinical management alongside with perspectives in altering gene expression. Copyright © 2012 S. Karger AG, Basel.